Risk of infections in patients with myeloproliferative neoplasms—a population-based cohort study of 8363 patients-Reference-Cited by-同舟云学术

Risk of infections in patients with myeloproliferative neoplasms—a population-based cohort study of 8363 patients

Published:2020-06-16 Issue:2 Volume:35 Page:476-484
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Landtblom Anna Ravn,Andersson Therese M-L,Dickman Paul W,Smedby Karin E,Eloranta Sandra,Batyrbekova Nurgul,Samuelsson Jan,Björkholm Magnus,Hultcrantz Malin^ORCID

Funder

Blodcancerfonden, the Cancer Research Foundations of Radiumhemmet

Åke Olsson Foundation for Hematologic Research, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet

Memorial Sloan-Kettering Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0909-7.pdf

Reference54 articles.

1. Blimark C, Holmberg E, Mellqvist UH, Landgren O, Bjorkholm M, Hultcrantz M, et al. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015;100:107–13.

2. Safdar A, Armstrong D. Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin Infect Dis. 2011;53:798–806.

3. Goldberg SL, Chen E, Corral M, Guo A, Mody-Patel N, Pecora AL, et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol. 2010;28:2847–52.

4. Barbui T, Thiele J, Gisslinger H, Finazzi G, Vannucchi AM, Tefferi A. The 2016 revision of WHO classification of myeloproliferative neoplasms: clinical and molecular advances. Blood Rev. 2016;30:453–9.